Galera Therapeutics Statistics
Total Valuation
GRTX has a market cap or net worth of 3.43 million. The enterprise value is -364,462.
| Market Cap | 3.43M |
| Enterprise Value | -364,462 |
Important Dates
The next estimated earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GRTX has 75.46 million shares outstanding. The number of shares has increased by 80.30% in one year.
| Current Share Class | 75.46M |
| Shares Outstanding | 75.46M |
| Shares Change (YoY) | +80.30% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.18% |
| Owned by Institutions (%) | 6.53% |
| Float | 44.19M |
Valuation Ratios
The trailing PE ratio is 0.07.
| PE Ratio | 0.07 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.01 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.00
| Current Ratio | 11.00 |
| Quick Ratio | 9.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -43.66% |
| Return on Invested Capital (ROIC) | -54.21% |
| Return on Capital Employed (ROCE) | -92.23% |
| Weighted Average Cost of Capital (WACC) | 14.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 21.17M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.84% in the last 52 weeks. The beta is 1.81, so GRTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | +27.84% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 57.17 |
| Average Volume (20 Days) | 93,753 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.04M |
| Pretax Income | 149.05M |
| Net Income | 63.52M |
| EBITDA | -6.02M |
| EBIT | -6.04M |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 6.38 million in cash and n/a in debt, with a net cash position of 6.38 million or 0.08 per share.
| Cash & Cash Equivalents | 6.38M |
| Total Debt | n/a |
| Net Cash | 6.38M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | 0.05 |
| Working Capital | 6.45M |
Cash Flow
| Operating Cash Flow | -6.05M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 20,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.30% |
| Shareholder Yield | -80.30% |
| Earnings Yield | 1,850.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |